Tradestie Institutional Equity Comparison Engine
SYK vs EW โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SYK Overall Edge
SYK Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Stryker Corporation (SYK) driven by superior Valuation, Options & Structure while EW counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, SYK trades at 19.0x Forward P/E with 24.0% operating margin (+7.6% YoY revenue) versus EW at 31.6x Forward P/E and 28.8% operating margin (+10.5% YoY). In options structure, SYK sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro) against EW sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
SYK
SYK 19.0x vs EW 31.6x Fwd P/E
Growth & Margin Winner
EW
Op Margin 24.0% vs 28.8% ยท YoY +7.6% vs +10.5%
Momentum & Technical Winner
EW
1Y -16.8% vs +23.9% ยท 52W Pos 36% vs 96%
Options & Structure Winner
SYK
SURGE (5th %ile IV) vs UNCLASSIFIED (34th %ile IV)
SYK
NYSE
Stryker Corporation
Surgical & Medical Instruments & Apparatus
$310.79
+0.37% 1D
Market Cap
$118.9B
1M Return
+5.47%
1Y Return
-16.77%
Forward P/E
19.0x
Unified AI Score
46.5 / 100
HOLD
Tech 37.0
Fund 49.0
Flow 58.0
Mom 60.0
EW
NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$106.66
-0.46% 1D
Market Cap
$60.8B
1M Return
+23.16%
1Y Return
+23.86%
Forward P/E
31.6x
Unified AI Score
31.5 / 100
SELL
Tech 50.0
Fund 29.0
Flow 51.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SYK -16.77%
EW +23.86%
Spread: +40.63 pp (EW Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SYK Revenue | EW Revenue | SYK Op. Margin | EW Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $13.6B | $3.72B | 18.7% | 20.1% | EW |
| FY2019 | $14.9B | $4.35B | 18.2% | 26.4% | EW |
| FY2020 | $14.3B | $4.39B | 15.5% | 20.5% | EW |
| FY2021 | $17.1B | $5.23B | 15.1% | 32.3% | EW |
| FY2022 | $18.4B | $4.46B | 15.4% | 33.6% | EW |
| FY2023 | $20.5B | $5.01B | 19.0% | 26.1% | EW |
| FY2024 | $22.6B | $5.44B | 16.3% | 25.3% | EW |
| FY2025 | $25.1B | $6.07B | 19.5% | 20.8% | EW |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SYK | EW | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $118.9B | $60.8B | Larger Scale | SYK |
| Trailing P/E Ratio Valuation | 33.3x | 61.5x | Lower Multiple | SYK |
| Forward P/E Ratio Valuation | 19.0x | 31.6x | Lower Multiple | SYK |
| Revenue Growth (YoY) Growth | +7.6% | +10.5% | Higher Growth | EW |
| Operating Margin (TTM) Profitability | 24.0% | 28.8% | Higher Margin | EW |
| Net Profit Margin Profitability | 13.8% | 15.3% | Higher Margin | EW |
| Return on Equity (ROE) Capital Efficiency | 16.0% | 9.3% | Higher ROE | SYK |
| 52-Week Range Position Momentum | 36% ($267โ$389) | 96% ($75โ$108) | Stronger Trend | EW |
| Beta / 30D Volatility Risk Regime | 0.22ฮฒ ยท 50% Vol | 0.44ฮฒ ยท 24% Vol | Lower Realized Risk | EW |
| Unified Institutional Score Composite Signal | 46.5 / 100 (HOLD) | 31.5 / 100 (SELL) | Higher Composite | SYK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SYK vs EW Buy Guide
SYK
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
EW
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
34th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SYK nor EW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.